Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Duléry, Remy  [Clear All Filters]
Journal Article
Mohty, M., Duléry, R., Gauthier, J., Malard, F., Brissot, E., Aljurf, M., Bazarbachi, A., Chabanon, C., Kharfan-Dabaja, M.A., Savani, B.N., et al. (2020). CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview.Bone Marrow Transplant.
De Philippis, C., Legrand-Izadifar, F., Bramanti, S., Giordano, L., de Oca, C.Montes, Duléry, R., Bouabdallah, R., Granata, A., Devillier, R., Mariotti, J., et al. (2020). Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma.Blood Adv4, 1242-1249.
Stocker, N., Duléry, R., Battipaglia, G., Brissot, E., Médiavilla, C., Sestili, S., Paviglianiti, A., Ledraa, T., Mohty, R., Bazarbachi, A., et al. (2019). Impact of Cyclosporine-A Concentration on Acute Graft-versus-Host Disease Incidence after Haploidentical Hematopoietic Cell Transplantation.Eur J Haematol.
Mohty, R., Brissot, E., Battipaglia, G., Ruggeri, A., Duléry, R., Bonnin, A., Médiavilla, C., Sestili, S., Belhocine, R., Vekhoff, A., et al. (2019). Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation.Br J Haematol.
Manson, G., Mear, J.-B., Herbaux, C., Schiano, J.-M., Casasnovas, O., Stamatoullas, A., Deau, B., Schmitt, A., Garnier, G., Regny, C., et al. (2019). Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation.Eur J Cancer115, 47-56.